PrescriptionDrug-Info.com - The People's Medicine Community ®

Xolair Forums

Read & contribute to the Xolair discussion threads below.
No registration is required and your identity remains anonymous. You can feel comfortable posting any details.

Home >> Xolair >> Xolair Discussions

Start a new discussion about Xolair

Page of 1
Xolair Warning Label Both the FDA and Health Canada have issued warnings about this pharmaceutical. FDA Proposes to Strengthen Label Warning for Xolair February 21, 2007 - "The Food and Drug Administration (FDA) announced that it has requested Genentech, Inc. add a boxed warning to the product label for omalizumab, marketed as Xolair. The boxed warning emphasizes that Xolair, used to treat patients with asthma related to allergies, may cause anaphylaxis. Anaphylaxis may include trouble breathing, chest tightness, dizziness, fainting, itching and hives, and swelling of the mouth and throat. In addition, FDA has asked Genentech to revise the Xolair label and provide a Medication Guide for patients to strengthen the existing warning for anaphylaxis." http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108850.htm Early Communication about an Ongoing Safety Review of Omalizumab (marketed as Xolair) July 16, 2009 - "FDA is evaluating interim safety findings from an ongoing study of Xolair (omalizumab) that suggests an increased number of cardiovascular and cerebrovascular adverse events in a group of patients using Xolair compared to a group of patients not given the drug (control group). Xolair is approved for use by adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who test positive for reactivity to a perennial airborne allergen, and whose symptoms are inadequately controlled with inhaled corticosteroids. The ongoing study, titled Evaluating the Clinical Effectiveness and Long-Term Safety in Patients with Moderate to Severe Asthma (EXCELS), is an observational study of approximately 5000 Xolair treated patients and a control group of approximately 2500 non-Xolair treated patients. The primary objective of the EXCELS study is to assess the long-term safety profile of Xolair in patients followed for 5 years. Study patients are 12 years of age and older with moderate to severe persistent asthma and who have a positive skin test or blood test for an aeroallergen. The interim data, submitted by the manufacturer of Xolair (Genentech), suggests a disproportionate increase in ischemic heart disease, arrhythmias, cardiomyopathy and cardiac failure, pulmonary hypertension, cerebrovascular disorders, and embolic, thrombotic and thrombophlebitic events in patients treated with Xolair compared to the control group of patients not given the drug. FDA is not recommending any changes to the prescribing information for Xolair and is not advising patients to stop taking Xolair at this time. Until the evaluation of the EXCELS study is completed, healthcare providers and patients should be aware of the risks and benefits described in the prescribing information, as well as the new information from the ongoing EXCELS study that may suggest a risk of cardiovascular and cerebrovascular adverse events." http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafety...ucm172218.htm Friday, 8/14/2009 1:30:47 AM Post a Reply
Xolair MY SIDE EFFECTS ENCLUDE- SWELLING IN FEET AND LEGS UP TO THE KNEES. FEET ARE TENDER TO WALK ON MAINLY IN THE HEELS. MEMORY HAS NOT BEEN GOOD AND CANNOT CONCENTRATE. Wednesday, 9/6/2006 7:48:26 AM 1 Reply

Start a New Xolair Discussion

No registration is required - simply follow the 5 short steps below for your post to appear on the home page. People will be able to post replies back to you, sharing any information or common experiences. Your discussion will be added to the community for everyone to locate & read. If you need help identifying a drug: This is NOT the place for pill identification. It is for starting a new discussion pertaining to this drug only. Please submit a new topic to the community with the specific pill imprint details instead.
1) Your Name: *
This is whatever name or nickname you would like to be displayed for your post.
2) Discussion Title: *
This should be a summary / headline of what you are posting, and it is first thing that anybody sees.
3) Detailed Message: * PLEASE BE AS DETAILED AS POSSIBLE. You will increase your chances of getting a faster reply by being as specific as possible. The more information you include, the better!

4) Email Address (optional - stays hidden):
Providing an email address allows you to receive alerts whenever somebody posts a reply to your message.
Subscribe to Health News Daily Newsletter - Top headlines emailed to you each evening
5) Enter the Security Code (Case Sensitive): Used to prevent forum spam and abuse.
*Legal & Privacy Notes* - Posts are subject to editing and may not appear immediately. There may be a delay for your post to appear on the home page. - Your identity remains anonymous (even from us). Providing an email address allows you to receive automatic notifications of replies. - Posting to the community does NOT subscribe you to an email list UNLESS you select the above option to receive the daily newsletter. - You agree to be bound by this site's Terms of Use.

This information has been independently compiled and is for educational purposes only. It is not intended to be a substitute for face to face medical advice from a qualified healthcare professional. Please remember that the content within this community is totally compiled by users of this site. Our website displays many pages which do not contain any medical information regarding the drug name stated. These pages are only provided for the purpose of opening community discussions about that drug by our users. For more details please see the Disclaimer. This data is Copyright © 2005-2009 PrescriptionDrug-Info.com and is protected under U.S. and International Copyright laws. All Rights Reserved.
Forums/drug_forums.asp Last Updated August 14 2009

Home Page

Post Your Story or Question

Registered Community Experts
Topics Submitted

Prescription Drug Forums

Top 200 Prescription Drugs

Drugs by Category

Recent FDA Approvals

November 2009 Health News

Advertising & Contact Details

About the Community

Medical Disclaimer

Make Us Your Home Page

Bookmark this Page

Free Daily Health News

Recent Topics

Eth255 Purple Round Pill M 30 Cialys Pill Light Blue M 30 Lyrica Dosage Pill Found R Peach Xofen Marinal Alprazolam White Pill Ps Oxycontin M Phentermine Qualis 58 93 E104 255 Yellow Tablet Pill 194 Blue Oxybutynin Mefenamic Acid 30 M Percocet 30mg Baralgan Pill That Yellow For Pain Flumarizina Azole White Pill R Lorcet Plus Cetirizine H 403 223 White Round 1 8 A Yellow Oblong Information On A Drug Prescribed By Your Physician

Committed to Your Privacy

We comply with the
HONcode standard for
trustworthy health
information: Verify Here

PrescriptionDrug-Info.com ~ 3835R E. Thousand Oaks Blvd # 175 ~ Westlake Village, CA 91362 ~ USA
See the Disclaimer, Terms of Use, and Privacy Policy for information concerning the use of this site.
Copyright © 2005-2009 PrescriptionDrug-Info.com. All Rights Reserved.